
Nurith Aizenman
[Copyright 2024 NPR]
-
Vaccines may not be as effective for those who are immuno-compromised. Protecting them needs to be made a top priority, says researchers — to keep them safe and to slow the emergence of variants.
-
Thanks to widespread vaccinations, the U.S. is reopening. Meanwhile, countries without similar access to doses are angry and fearful — amid signs the COVID-19 catastrophe in India could spread.
-
African nations had been counting on Serum Institute of India for nearly all their COVID vaccines. Now the company says it won't be sending any more for months. And African officials are scrambling.
-
India's freeze on AstraZeneca exports is upending Africa's already limited vaccination progress, as the Africans who got their first dose are coming due for their second with no supply in sight.
-
How the chaotic system for distributing the world's vaccine supply is wreaking havoc in places that can least afford it.
-
While many African countries need more COVID-19 vaccines, others are struggling to administer the shots they have. Malawi and South Sudan have even had to throw out unused and expired doses.
-
One of the hottest areas of research right now: studies to determine how well current vaccines work against emerging coronavirus "variants of concern."
-
It's one of the hottest areas of COVID-19 research: How well do the various vaccines work against the variants? New findings are coming out daily. Here's what's known so far, and what's pending.
-
The grim news of mass shootings in California has again cast a spotlight on the gun violence death rate in the U.S., which is higher than much of the world.
-
For this health expert based in Boston, the effort to get vaccines to his native South Africa was intensely personal.